How to write a world-class paper: a formula for success?

UMCG, Nov 2014

Peter de Jonge Interdisciplinary Center Psychopathology and Emotion RegulationUMCG University of Groningenpeter.de.jonge@umcg.nl

Prognostic association of depression following myocardial

infarction with mortality and cardiovascular events: A meta-

analysis. Van Melle JP, de Jonge, P, Spijkerman TA,

Tijssen JGP, Ormel J, van Veldhuisen DJ, van den Brink RHS,

van den Berg MP. Psychosom Med 2004.

As of May/June 2014, this highly cited paper received enough citations to place it in the top 1% of the academic field of Psychiatry/Psychology based on a highly cited threshold for the field and publication year.

Data from Essential Science Indicators ℠

Lesson 1: When it is possible to do the study better than

you intended, do it better.

Lesson 2: don’t be afraid to build on your good name / never change a winning team

Prognostic association of depression following

myocardial infarction with mortality and cardiovascular

events: a meta-analysis of 25 years of research. Meijer A

, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge, P.

Gen Hosp Psych 2011

Lesson 2: don’t be afraid to build on your good name / never change a winning team

Prognostic association of depression following

myocardial infarction with mortality and cardiovascular

events: a meta-analysis of 25 years of research. Meijer A

, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge, P.

Gen Hosp Psych 2011

•Times Cited: 73

Prognostic Association of Anxiety Post Myocardial Infarction With Mortality and New Cardiac Events: A Meta-Analysis. Roest AM, Martens EJ, Denollet J, de Jonge P. Psychosom Med 2010.

Lesson 3: dedicate your efforts to find an appropriate journal

where your paper will actually be read an referred to.

What is more important: a high-impact journal or being

cited?

van der Werf SY, Kaptein KI, de Jonge P, Korf J.

Major depressive episodes and random mood. JAMA-Psych

2006

Times Cited: 9

Lesson 4: Look for (external) excellent partners

Average Citations per Item : 29.19

h-index : 47

Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart DiseaseWhooley MA, de Jonge P, Vittinghoff E, et al. JAMA 2008

As of May/June 2014, this highly cited paper received

enough citations to place it in the top 1% of the

academic field of Clinical Medicine based on a highly

cited threshold for the field and publication year

Lesson 5: Sometimes you just know it is going to be good.

Depression Screening and Patient Outcomes in Cardiovascular Care A Systematic Review

. Thombs BD, de Jonge P, Coyne JC, et al. JAMA 2008.

Times Cited: 208

Lesson 6: And sometimes you don’t

Response sets in self-report data and their associations with

personality traits. De Jonge P, Slaets, JPJ. Eur J Psych 2005.

Times Cited: 8

Lessons

Lesson 1: When it is possible to do the study better than you

intended, do it better.

Lesson 2: Don’t be afraid to build on your good name / never

change a winning team

Lesson 3: Dedicate your efforts to find an appropriate journal

where your paper will actually be read an referred to

Lesson 4: Look for (external) excellent partners

Lesson 5: Sometimes you just know it is going to be good

Lesson 6: And sometimes you don’t

Prospective validation

Turner EH, et al. Selective publication of antidepressant trials

and its influence on apparent efficacy (in depression). NEJM

2008

Times Cited: 793

How about anxiety?

A good idea…

2011: Dutch Brain Foundation

2012: Annelieke Roest to Oregon USA

2013: Hard work / little time

2014: June, manuscript submitted to JAMA

Efficacy of SSRIs/SNRIs

Roest AM, Jonge P, Williams CD, de Vries YA, Schoevers RA, Turner EH.

GAD 0.35 (0.28-0.43)

PD 0.35 (0.25-0.45)

SAD 0.42 (0.35-0.49)

PTSD 0.32 (0.14-0.50)

OCD 0.41 (0.30-0.51)

GAD 0.32 (0.25-0.39)

PD 0.28 (0.19-0.36)

SAD 0.39 (0.30-0.49)

PTSD 0.27 (0.11-0.44)

OCD 0.39 (0.30-0.49)

Small, overestimated and

Real efficacy

MDD 0.32 (0.27-0.35) (turner et al 2008)

Apparent efficacy

MDD 0.41 (0.36-0.45)

interchangeable across disorders

RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants

in the treatment of anxiety disorders

Dear Dr. Roest: August 10, 2014

Thank you for submitting your manuscript to JAMA. Based on

our editorial evaluation and the comments of our peer

reviewers, I regret to inform you that we will not accept your

manuscript for publication. However, as you are aware, the

JAMA Network allows submitted manuscripts to have more

than one opportunity for evaluation for publication. This

network includes JAMA Psychiatry...

RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants

in the treatment of anxiety disorders

Dear Dr. Roest: September 30, 2014

We have completed our review of your manuscript and are

considering accepting it for publication in JAMA Psychiatry,

provided that it is suitably revised to address the criticisms

and suggestions of the reviewers……

RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants

in the treatment of anxiety disorders

Dear Dr. Roest: November 4, 2014

Based on our evaluation, I regret to inform you that we will

not pursue the manuscript you have submitted for publication.

We are a journal of general psychiatric research, and your

paper, in our view, would be more appropriate for a

subspecialty journal such as Am J Geriatric Psychiatry.

=>I hope that you are willing to check whether something

went wrong in the editorial process.

From: Coyle, Joseph T. [joseph_coyle@hms.harvard.edu]

Sent: woensdag 5 november 2014 21:26

Subject: RE: PSY14-0799R Wrong Decision Letter??

Sorry. An electronic mistake. We will send the revision out for

review by previous reviewers.

RE: Reporting bias in clinical trials investigating the efficacy of second generation antidepressants

in the treatment of anxiety disorders

Is it going to be a world-class paper?

Lessons

Lesson 1: When it is possible to do the study better than you

intended, do it better

Lesson 2: Don’t be afraid to build on your good name / never

change a winning team

Lesson 3: Dedicate your efforts to find an appropriate journal

where your paper will actually be read an referred to

Lesson 4: Look for excellent (internal and external) partners

Lesson 5: Sometimes you just know it is going to be good

Lesson 6: And sometimes you don’t

Lesson 7: You can only write a world-class paper when you

quit writing non world-class papers

Lesson 8: Be a judge of your own work

Thank you for your attention